Implementation barrier | Explanation |
---|---|
Intensified prescriber training | Intensifying training requirements for correct TACT prescription |
Donor funder support | Obtaining support by donor funders to cover TACT implementation costs and potential price increases |
National policy support | Obtaining support from national malaria control programs and other national decision makers to engage in the deployment of TACT |
WHO and global policy support | Obtaining support from the WHO and other global decision makers to engage in the deployment of TACT |
Availability of fixed-dose combination (FDC) TACT | Ensuring timely development and production of fixed-dose combination (FDC) for TACT |
Community acceptance | Ensuring community acceptance by providing clear communication and tackling potential misconceptions about TACT |
Collecting safety and efficacy data | Collecting sufficient efficacy and safety data to support the introduction of TACT |
Supply chain logistics | Adapting import, procurement and supply routes for the introduction of TACT |
Regulatory approval | Obtaining timely regulatory approval for introducing TACT in Southeast Asia |
Set up surveillance systems | Setting up surveillance systems to monitor drug resistance rates and adherence to TACT |
Private sector engagement | Engaging the (informal) private sector in TACT deployment and creating demand beyond official programs |
Set up pharmacovigilance systems | Setting up a pharmacovigilance system for TACT |
Stockpile management | Managing stockpiles for countries that still have ACT stocks or contract deals with ACT producers |